Medical
Perspectives from one Australian team’s search for a COVID-19 vaccine
Medical News: While it may not be here tomorrow, scientists around the world are racing to develop viable COVID-19 vaccine candidates.
In this podcast episode, two Australian researchers from The University of Queensland share how their team identified a lead vaccine candidate from an initial field of 200 in just over 5 weeks.
Dodi Axelson, Head of Communications, Cytiva, Sweden and Conor McKechnie, Vice President Marketing, Cytiva, United Kingdom share the perspectives of:
- Trent Munro, Professor & Senior Group Leader at the Australian Institute for Bioengineering Nanotechnology and
- Keith Chappell, Associate Professor & Affiliate Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology from The University of Queensland.
Discovery Matters is a collection of stories and insights on matters of discovery that advance science and medicines. Brought to you by the curious people at Cytiva.
News & Trends - MedTech & Diagnostics
$54 million cancer centre opens in one of Australia’s fastest growing communities
MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreNews & Trends - MedTech & Diagnostics
Queensland elevates diagnostic precision with cutting-edge imaging technology
MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]
MoreNews & Trends - Pharmaceuticals
Landmark collaboration sparks inauguration of precision care clinic
Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]
More